Cited by 38Neonatal and fetal brain pathologyCerebral Palsy and Movement DisordersPregnancy and preeclampsia studies

Neuronal Nitric Oxide Synthase Inhibition Prevents Cerebral Palsy following Hypoxia-Ischemia in Fetal Rabbits: Comparison between JI-8 and 7-Nitroindazole

Open access
Yu, Lei, Derrick, Matthew, Ji, Haitao, Silverman, Richard B., Whitsett, Jennifer, Vásquez-Vivar, Jeannette, Tan, Sidhartha·2011·Developmental Neuroscience

Abstract

Cerebral palsy and death are serious consequences of perinatal hypoxia-ischemia (HI). Important concepts can now be tested using an animal model of cerebral palsy. We have previously shown that reactive oxygen and nitrogen species are produced in antenatal HI. A novel class of neuronal nitric oxide synthase (nNOS) inhibitors have been designed, and they ameliorate postnatal motor deficits when administered prior to the hypoxic-ischemic insult. This study asks how the new class of inhibitors, using JI-8 (K i for nNOS: 0.014 µ M) as a representative, compare with the frequently used nNOS inhibitor 7-nitroindazole (7-NI; K i: 0.09 ± 0.024 µ M). A theoretical dose equivalent to 75 K i of JI-8 or equimolar 7-NI was administered to pregnant rabbit dams 30 min prior to and immediately after 40 min of uterine ischemia at 22 days gestation (70% term). JI-8 treatment resulted in a significant decrease in NOS activity (39%) in fetal brain homogenates acutely after HI, without affecting maternal blood pressure and heart rate. JI-8 treatment resulted in 33 normal kits, 2 moderately and 13 severely affected kits and 5 stillbirths, compared with 8 normal, 3 moderately affected and 5 severely affected kits and 10 stillbirths in the 7-NI group. In terms of neurobehavioral outcome, 7-NI was not different from saline treatment, while JI-8 was superior to saline and 7-NI in its protective effect (p < 0.05). In the surviving kits, JI-8 significantly improved the locomotion score over both saline and 7-NI scores. JI-8 was also significantly superior to saline in preserving smell, muscle tone and righting reflex function, but 7-NI did not show significant improvement. Furthermore, a 100-fold increase in the dose (15.75 µmol/kg) of 7-NI significantly decreased systolic blood pressure in the dam, while JI-8 did not. The new class of inhibitors such as JI-8 shows promise in the prevention of cerebral palsy and is superior to the previously more commonly used nNOS inhibitor.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000327244

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 39 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Yu, L., Derrick, M., Ji, H., Silverman, R. B., Whitsett, J., Vásquez-Vivar, J., & Tan, S.
Affiliations
  • Endeavor Health (US)
  • Medical College of Wisconsin (US)
Venue
Developmental Neuroscience
Publisher
S. Karger AG
Published
2011
Volume
33
Issue
3-4
Pages
312-319
ISSN
  • 0378-5866 (ISSN-L)
  • 1421-9859
OpenAlex
W2091163223
Cited by
38
References
39
Citations by year
2024: 2 · 2023: 6 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 6 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 6 · 2012: 2
FWCI
2.95
Type
journal article
Language
en
Open access
Locations
  • Developmental Neuroscience (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of General Medical Sciences (GM049725, R01GM049725)
  • National Institute of Neurological Disorders and Stroke (NS 043285, R01NS043285, NS063141, R01NS051402, R56NS043285, NS051402, R21NS063141)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
  • Health Sciences › Medicine › Psychiatry and Mental health › Cerebral Palsy and Movement Disorders
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Keywords
neuronal nitric oxide synthase inhibition, cerebral palsy prevention, hypoxia-ischemia, 7-nitroindazole, perinatal hypoxia-ischemia, fetal brain, neuroprotection, reactive oxygen and nitrogen species, neurobehavioral outcomes, locomotion, maternal blood pressure, rabbit fetus, uterine ischemia
MeSH terms
Animals, Animals, Newborn, Cerebral Palsy, Enzyme Inhibitors, Female, Fetus, Humans, Indazoles, Neuropsychological Tests, Pregnancy, Rabbits, Hypoxia-Ischemia, Brain, Nitric Oxide Synthase Type I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review